Jeon, Ki-Hyun
Jeong, Young-Hoon
Chae, In-Ho
Kim, Byeong-Keuk
Joo, Hyung Joon
Chang, Kiyuk
Park, Yongwhi
Song, Young Bin
Ahn, Sung Gyun
Lee, Sang Yeub
Cho, Jung Rae
Her, Ae-Young
Kim, Hyo-Soo
Kim, Moo Hyun
Lim, Do-Sun
Shin, Eun-Seok
Suh, Jung-Won
,
Article History
Received: 17 June 2023
Accepted: 27 August 2023
First Online: 7 September 2023
Declarations
:
: The institutional review board of each participating center approved the registry and waived the requirement for written informed consent for access to an institutional registry. The study was performed in accordance with the Good Clinical Practice Guidelines and the principles of the Declaration of Helsinki.
: All authors approved submission of the paper.
: Dr. Jeong has received honoraria for lectures from AstraZeneca, Daiichi Sankyo, Sanofi-Aventis, Han-mi Pharmaceuticals, and Yuhan Pharmaceuticals, as well as research grants or support from Yuhan Pharmaceuticals and U&I Corporation. Dr. Song has received honoraria for lectures from AstraZeneca, Daiichi Sankyo, Sanofi-Aventis, Bayer Korea, and Samjin Pharmaceutical. Dr. Joo has received honoraria for lectures from AstraZeneca, Hanmi, Samjin, Dong-A, HK inno. N Pharmaceuticals, and DIO Medical Ltd. The other authors have no potential conflicts of interest to disclose.